Increased urinary zinc excretion in cancer patients is linked to immune activation and renal tubular cell dysfunction
Article Received: 13 May 1994 Accepted: 13 September 1994 Abstract
Urinary zinc excretion is known to be increased in cancer patients, but the pathogenesis of this phenomenon remains uncertain. Both skeletal muscle catabolism and renal tubular cell dysfunction have been proposed to explain this observation. We have investigated urinary zinc and
N-acetyl-β- d-glucosaminidase (NAG), an indicator of renal tubular cell dysfunction, as well as serum neopterin, an index of systemic immune activation, in 22 patients with cancer and seven controls. Both serum neopterin and urinary zinc were significantly elevated in cancer patients (15.8 ± 12.7 versus 7.3 ± 2.3 nmol l −1 and 1.77 ± 0.80 versus 1.21 ± 0.41 mmol mol −1 creatinine, P < 0 and P < 0.05, respectively), while NAG was similar in cancer patients and the controls (13.58 ± 13.80 versus 13.68 ± 12.19 μkat mol −1 creatinine). A significant correlation was observed between serum neopterin and urine zinc (rs = 0.5119, P < 0.02), serum neopterin and urine NAG (rs = 0.6761, P < 0.002), and urinary zinc and NAG (rs = 0.6348, P < 0.002). In conclusion, the present data indicate a link between urinary zinc excretion and immune activation as well as renal tubular cell dysfunction. In addition, renal tubular cell dysfunction appears to be linked to immune activation. Keywords cancer N-acetyl-β- d-glucosaminidase neopterin urine zinc References
Boosalis MG, Solem LD, Cerra FB
1991 Increased urinary zinc excretion after thermal injury.
J Lab Clin Med
Caversio J, Rizzoli R, Dayer J-M, Bonjour J-P. 1987 Interleukin-1 decreases renal sodium reabsorption: possible mechanism of endotoxin-induced natriuresis.
Am J Physiol
Chmielnicka J, Szymanska JA, Brzeznicka EA, Kaluzinski A. 1992 Changes in concentration of essential metals in kidneys and urine as indices of gentamycin nephrotoxicity in female Wistar rats.
Fell GS, Fleck A, Cuthbertson DP
1973 Urinary zinc levels as an indication of muscle catabolism.
Guder WG, Hofmann W. 1992 Markers for the diagnosis and monitoring of renal tubular lesions.
, Suppl 1, 3–7.
Honnorat J, Accominotti M, Broussolle C,
1992 Effects of diabetes mellitus type and treatment on zinc status in diabetes mellitus.
Biol Trace Elem Res
Horčičko J, Borovanský J, Kubíková M, Duchoň J, Duchková H. 1980 Urinary excretion of zinc and magnesium in malignant melanoma.
Clin Chim Acta
Huber C, Batchelor R, Fuchs D
1984 Immune response- associated production of neopterin. Release of macrophages primarily under control of interferongamma.
J Exp Med
Kirby KA, Rothenburg BA, Victery W, Vander AJ, Kluger MJ. 1982 Urinary excretion of zinc and iron following injection of bacteria in the unanesthetized rabbit.
Mineral Electrolyte Metab
Klaiman AP, Victery W, Kluger MJ, Vander AJ. 1981 Urinary excretion of zinc and iron following acute injection of dead bacteria in dog.
Proc Soc Exp Biol Med
Leaback DH, Walker PG. 1961 Studies on glucosaminidase. 4. The fluorimetric assay of
Mahajan SK, Abraham J, Migdal SD, Abu-Hamdan DK, McDonald FD. 1984 Effect of renal transplantation on zinc metabolism and taste acuity in uremia.
Melichar B. 1993 Association between urinary zinc and neopterin excretion: a manifestation of the acute phase response in the kidney?
Melichar B, Zeimet A, Artner-Dworzak E
1993 Association between increased urinary zinc and neopterin concentrations in women with gynecological cancer.
Tumor Diagn Ther
Price RG. 1992 The role of NAG (
-glucos aminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity.
, Suppl 1, 14–19.
Reibnegger G, Fuchs D, Fuith LC,
1991 Neopterin as a marker for activated cell-mediated immunity: application in malignant disease.
Cancer Detect Prev
Sunderman FW. 1973 Atomic absorption spectrometry of trace metals in clinical pathology.
Voyatzoglou V, Mountokalakis T, Tsata-Voyatzoglou V, Koutselinis A, Skalkeas G. 1982 Serum zinc levels and urinary zinc excretion in patients with bronchogenic carcinoma.
Am J Surg
Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. 1989 Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application.
Adv Clin Chem
Werner ER, Bichler A, Daxenbichler G,
1987 Determination of neopterin in serum and urine.
Yuzbasiyan-Gurkan VA, Brewer GJ, Vander AJ, Guenther MJ, Prasad AS. 1989 Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anaemia.
Am J Hematol
Google Scholar Copyright information
© Rapid Communications of Oxford Ltd 1995